Exozymes Income Statement (2023-2024) | EXOZ

1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024
Revenue & cost
Revenue (Quarter) -700.00-0.04M
Operating items
Research & Development (Quarter) 0.03M0.46M0.28M0.24M0.02M1.84M
Wages, Salaries and Other (Quarter) 0.12M0.31M0.26M0.73M0.55M-0.50M
Selling, General & Administrative (Quarter) 0.36M0.52M0.73M1.09M0.89M1.35M
Restructuring Costs (Quarter) 0.15M0.08M0.08M0.06M0.06M0.13M
Other Operating Expenses (Quarter) -0.15M-0.08M-0.08M-0.06M0.65M-1.34M
Operating Expenses (Quarter) 0.39M0.98M1.01M1.33M1.61M1.98M
Operating Income (Quarter) -0.39M0.39M-1.01M-1.33M-1.61M-1.98M
EBIT (Quarter) -0.39M0.39M-1.01M-1.33M-1.61M-1.98M
Non-operating items
Interest & Investment Income (Quarter) -0.03M-0.04M0.15M
Other Non Operating Income (Quarter) -0.13M-0.07M
Net income details
EBT (Quarter) -0.52M-1.06M-1.01M-1.36M-1.66M-1.84M
Tax Provisions (Quarter) 0.00M-1.00
Profit After Tax (Quarter) -0.52M-1.10M-1.01M-1.36M-1.66M-1.84M
Income from Continuing Operations (Quarter) -0.52M-1.06M-1.01M-1.36M-1.66M-1.84M
Consolidated Net Income (Quarter) -0.52M-1.06M-1.01M-1.36M-1.66M-1.84M
Income towards Parent Company (Quarter) -0.52M-1.06M-1.01M-1.36M-1.66M-1.84M
Net Income towards Common Stockholders (Quarter) -0.52M-1.06M-1.01M-1.36M-1.66M-1.84M
Additional items
EPS (Basic) (Quarter) -0.08-0.18-0.16-0.22-0.27-0.25
EPS (Weighted Average and Diluted) (Quarter) -0.08-0.18-0.16-0.22-0.27-0.25
Shares Outstanding (Weighted Average) (Quarter) 6.25M6.25M6.25M6.25M6.25M
Shares Outstanding (Diluted Average) (Quarter) 6.25M6.25M6.25M6.25M6.25M
EBITDA (Quarter) -0.39M0.39M-1.01M-1.33M-1.61M-1.98M
Interest Expenses (Quarter) 0.04M
Shares Outstanding (Quarter) 6.25M6.25M6.25M6.25M6.25M
Tax Rate (Quarter) -0.160.00